Hopp til innhold

Valgte elementer er lagt i handlekurven

Gå til handlekurv

Artikkel

Publikasjonsliste for Meldingssystem for smittsomme sykdommer (MSIS)

Publisert Oppdatert

Colourbox.com
Colourbox.com

Oversikt over forskningsartikler der data fra Meldingssystem for smittsomme sykdommer (MSIS) er brukt.


Hopp til innhold

Har du funnet en feil?

Forskere og andre kan be om tilgang til statistikk eller data fra Meldingssystem for smittsomme sykdommer (MSIS) og de andre helseregistrene som Folkehelseinstituttet er databehandlingsansvarlig for. Helseregistre er en unik kilde til kunnskap om befolkningens helse, årsaker til sykdom og kvaliteten på helse- og omsorgstjenestene.

Dette er en oversikt over artikler fra forskning hvor helseregistre er brukt som datakilde, publisert i vitenskapelige tidsskrift. Listene er basert på metodiske søk i internasjonale artikkeldatabaser. De vil kunne være ufullstendige, avhengig av hvordan kildeopplysningene er angitt i artiklene.

For å søke om tilgang til statistikk, data eller biologisk materiale fra helseregistre eller helseundersøkelser som Folkehelseinstituttet forvalter, må du benytte elektronisk søknadsskjema.

2018

Ruiz PLD, Tapia G, Bakken IJ, Hasberg SE, Hungnes O, Gulseth HL, et al. Pandemic influenza and subsequent risk of type 1 diabetes: a nationwide cohort study. Diabetologia 2018;61(9):1996-2004. https://www.ncbi.nlm.nih.gov/pubmed/29934759

Laake I, Tunheim G, Anna Hayman R, Hungnes O, Waalen K, Håberg SE, et al. Risk of pregnancy complications and adverse birth outcomes after maternal A(H1N1)pdm09 influenza: a Norwegian population-based cohort study. BMC Infect Dis 2018;18. https://www.ncbi.nlm.nih.gov/pubmed/30348103

MacDonald E, White R, Mexia R, Bruun T, Kapperud G, Brandal LT, et al. The role of domestic reservoirs in domestically acquired Salmonella infections in Norway: epidemiology of salmonellosis, 2000-2015, and results of a national prospective case-control study, 2010-2012. Epidemiol Infect 2018:1-8. https://www.ncbi.nlm.nih.gov/pubmed/30428947

Winje BA, White R, Syre H, Skutlaberg DH, Oftung F, Mengshoel AT, et al. Stratification by interferon- release assay level predicts risk of incident TB. Thorax 2018;73(7):652-61. https://www.ncbi.nlm.nih.gov/pubmed/29622693

Gounder PP, Koch A, Provo G, Lovlie A, Ederth JL, Axelsson M, et al. Summary of available surveillance data on hepatitis C virus infection from eight Arctic countries, 2012 to 2014 separator. Eurosurveillance 2018;23(40). https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2018.23.40.1700408

Mysterud A, Vetle Malmer S, Seland IV, Herland A, Easterday WR, Jore S, et al. Tick abundance, pathogen prevalence, and disease incidence in two contrasting regions at the northern distribution range of Europe. Parasites & Vectors 2018;11. https://www.ncbi.nlm.nih.gov/pubmed/29788994

Schein YL, Madebo T, Andersen HE, Arnesen TM, Dyrhol-Riise AM, Tveiten H, et al. Treatment completion for latent tuberculosis infection in Norway: a prospective cohort study. BMC Infect Dis 2018;18(1):587. https://www.ncbi.nlm.nih.gov/pubmed/30453946

Johansen TB, Scheffer L, Jensen VK, Bohlin J, Feruglio SL. Whole-genome sequencing and antimicrobial resistance in Brucella melitensis from a Norwegian perspective. Scientific Reports (Nature Publisher Group) 2018;8:1-9. https://www.ncbi.nlm.nih.gov/pubmed/29559127

Beauté J, Westrell T, Schmid D, Müller L, Epstein J, Kontio M, Couturier E, Faber M, Mellou K, Borg ML, Friesema I, Vold L, Severi E. Travel-associated hepatitis A in Europe, 2009 to 2015. Euro Surveill 2018;23(22). https://doi.org/10.2807/1560-7917.ES.2018.23.22.1700583

Riise ØR, Laake I, Vestrheim D, Winje BA, Moster D, Storsæter J. Preterm Children Have Higher Risk Than Full-Term Children of Invasive Pneumococcal Disease During the First Two Years of Life. Pediatr Infect Dis J 2018; Mar 21. doi: 10.1097/INF.0000000000001989. [Epub ahead of print]. https://journals.lww.com/pidj/Abstract/publishahead/Preterm_Children_Have_Higher_Risk_Than_Full_Term.96693.aspx

Steens A, Winje BA, White RA, Odsbu I, Brantsaeter AB, Vestrheim DF. Indirect effects of pneumococcal childhood vaccination in individuals treated with immunosuppressants in ambulatory care: a case-cohort study. Clinical Infectious Diseases 2018 Aug 25. [Epub ahead of print]. 
https://www.ncbi.nlm.nih.gov/pubmed/30957160 

Veneti L, Borgen K, Borge KS, Dansi K, Greve-Isdahl M, Konsmo K, Njølstad G, Nordbø SA, Øystese KS, Rykkvin R, Sagvik E, Riise ØR. Large outbreak of mumps virus genotype G among vaccinated students in Norway, 2015 to 2016. Euro Surveill 2018;23(38). ES.2018.23.38.1700642. https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2018.23.38.1700642

2017

Andreassen AES, Jacobsen CM, de Blasio B, White R, Kristiansen IS, Elstrom P. The impact of methicillin-resistant S. aureus on length of stay, readmissions and costs: a register based case-control study of patients hospitalized in Norway. Antimicrob 2017;6:74

Blomfeldt A, Larssen KW, Moghen A, Gabrielsen C, Elstrom P, Aamot HV, et al. Emerging multidrug-resistant Bengal Bay clone ST772-MRSA-V in Norway: molecular epidemiology 2004-2014. European Journal of Clinical Microbiology and Infectious Diseases 2017;36(10):1911-21.

Egenberg HEI, Henriette; Karlsrud, Anniken; Weisser, Kristin Howlid; Ødegård, Marianne Meier; Majeed, Heidi Vego. Pneumokokkvaksinasjon av eldre på sykehjem. Et kvalitetsforbedringsprosjekt ved Modumheimen Sykehjem [Master thesis]: Universitet i Oslo; 2017.

Francesco Di R, Bjørnholt JV, Leegaard TM, Fossum Moen AE, Birgitte Freiesleben de B. MRSA infections in Norway: A study of the temporal evolution, 2006-2015. PLoS One 2017;12(6).

Haukaas FS, Arnesen TM, Winje BA, Aas E. Immigrant screening for latent tuberculosis in Norway: a cost-effectiveness analysis. The European Journal of Health Economics : HEPAC 2017;18(4):405-15.

Lill T, Bakken IJ, Gunnes N, Ghaderi S, Stoltenberg C, Magnus P, et al. Narcolepsy and hypersomnia in Norwegian children and young adults following the influenza A(H1N1) 2009 pandemic. Vaccine 2017;35(15):1879-85.

Meijerink H, White RA, Lovlie A, Birgitte Freiesleben de B, Dalgard O, Amundsen EJ, et al. Modelling the burden of hepatitis C infection among people who inject drugs in Norway, 1973-2030. BMC Infect Dis 2017;17.

Mysterud A, Jore S, Østerås O, Viljugrein H. Emergence of tick-borne diseases at northern latitudes in Europe: a comparative approach. Scientific Reports (Nature Publisher Group) 2017;7:1-12.

PÄRn T, Dahl V, Lienemann T, Perevoscikovs J, De Jong B. Multi-country outbreak of Salmonella enteritidis infection linked to the international ice hockey tournament. Epidemiology and Infection 2017;145(11):2221-30.

Samuelsen Ø, Overballe-Petersen S, Bjørnholt JV, Brisse S, Doumith M, Woodford N, et al. Molecular and epidemiological characterization of carbapenemase-producing Enterobacteriaceae in Norway, 2007 to 2014. PLoS One 2017;12(11).

Årdal C, Blix HS, Plahtea J, Røttingen J-A. An antibiotic's journey from marketing authorization to use, Norway/Parcours d'un antibiotique, de son autorisation de mise sur le marché à son utilisation, en Norvège/El recorrido de un antibiótico desde la autorización de comercialización a su uso en Noruega. World Health Organization Bulletin of the World Health Organization 2017;95(3):220-6.

2016

Abitbol, C. L., & Moxey-Mims, M. (2016). Chronic kidney disease: Low birth weight and the global burden of kidney disease. Nature Reviews Nephrology, 12(4), 199-200. doi:https://dx.doi.org/10.1038/nrneph.2016.19

Bourgeois, A. C., Zulz, T., Soborg, B., Koch, A., & International Circumpolar Surveillance--Tuberculosis Working, G. (2016). Descriptive review of tuberculosis surveillance systems across the circumpolar regions. International Journal of Circumpolar Health, 75, 30322. doi:https://dx.doi.org/10.3402/ijch.v75.30322

Guzman-Herrador, B., de Blasio, B. F., Lund, V., MacDonald, E., Vold, L., Wahl, E., & Nygard, K. (2016). [Waterborne outbreaks in Norway 2003-2012]. Tidsskrift for den Norske Laegeforening, 136(7), 612-616. doi:https://dx.doi.org/10.4045/tidsskr.15.0114

MacDonald, E., Einoder-Moreno, M., Borgen, K., Brandal, L. T., Diab, L., Fossli, O., . . . Nygard, K. (2016). National outbreak of Yersinia enterocolitica infections in military and civilian populations associated with consumption of mixed salad, Norway, 2014. Eurosurveillance, 21(34), 11-19. doi:10.2807/1560-7917.es.2016.21.34.30321

MacDonald, E., Vestrheim, D. F., White, R. A., Konsmo, K., Lange, H., Aase, A., . . . Vold, L. (2016). Are the current notification criteria for Lyme borreliosis in Norway suitable? Results of an evaluation of Lyme borreliosis surveillance in Norway, 1995-2013. BMC Public Health, 16, 729. doi:https://dx.doi.org/10.1186/s12889-016-3346-9

Midgard, H., Bramness, J. G., Skurtveit, S., Haukeland, J. W., & Dalgard, O. (2016). Hepatitis C Treatment Uptake among Patients Who Have Received Opioid Substitution Treatment: A Population-Based Study. PloS One, 11(11), e0166451. doi:https://dx.doi.org/10.1371/journal.pone.0166451

Nguipdop-Djomo, P., Heldal, E., Rodrigues, L. C., Abubakar, I., & Mangtani, P. (2016). Duration of BCG protection against tuberculosis and change in effectiveness with time since vaccination in Norway: a retrospective population-based cohort study. The Lancet Infectious Diseases, 16(2), 219-226. doi: https://dx.doi.org/10.1016/S1473-3099(15)00400-4

2015

Arnesen, T. M., Seterelv, S., Norheim, G., Helgebostad, S. R., Mannsaker, T., Ly, I. N., . . . Steen, T. W. (2015). Tuberculosis outbreak in Eastern Norway. Tidsskrift for den Norske Laegeforening, 135(23-24), 2160-2164.

Guzman Herrador, B. R., Ronning, K., Borgen, K., Mannsaker, T., & Dahle, U. R. (2015). Description of the largest cluster of tuberculosis notified in Norway 1997-2011: is the Norwegian tuberculosis control programme serving its purpose for high risk groups? BMC Public Health, 15, 367.

Klovstad, H., & Aavitsland, P. (2015). Denominators count: supplementing surveillance data for genital Chlamydia trachomatis infection with testing data, Norway, 2007 to 2013. Eurosurveillance, 20(36), 20-27.

MacDonald, E., White, R., Mexia, R., Bruun, T., Kapperud, G., Lange, H., . . . Vold, L. (2015). Risk Factors for Sporadic Domestically Acquired Campylobacter Infections in Norway 2010-2011: A National Prospective Case-Control Study. PLoS ONE [Electronic Resource], 10(10), e0139636.

Magnus, P., Gunnes, N., Tveito, K., Bakken, I. J., Ghaderi, S., Stoltenberg, C., . . . Haberg, S. E. (2015). Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is associated with pandemic influenza infection, but not with an adjuvanted pandemic influenza vaccine. Vaccine, 33(46), 6173-6177.

Munson, S., Raluy-Callado, M., Lambrelli, D., Wasiak, R., Eriksson, D., & Gray, S. (2015). Clinical burden of pneumonia, meningitis and septicemia in Norway 2 years after 7-valent pneumococcal conjugate vaccine introduction. Scandinavian Journal of Public Health, 43(6), 657-666.

Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is associated with pandemic influenza infection, but not with an adjuvanted pandemic influenza vaccine. Magnus, P., Gunnes, N., Tveito, K., Bakken, I. J., Ghaderi, S., Stoltenberg, C., Haberg, S. E. (2015). Vaccine, 33(46), 6173-6177.

MSIS fyller 40 år. A Løvlie, H Blystad, T Bruun. Nr. 23/24 – 15. desember 2015. Tidsskr Nor Legeforen. 2015; 135:2136 – 7. http://www.ncbi.nlm.nih.gov/pubmed/26674030

2014

Haugum, K., Brandal, L. T., Lindstedt, B. A., Wester, A. L., Bergh, K., & Afset, J. E. (2014). PCR-based detection and molecular characterization of shiga toxin-producing Escherichia coli strains in a routine microbiology laboratory over 16 years. Journal of Clinical Microbiology, 52(9), 3156-3163.

Jakopanec, I., Grjibovski, A. M., Nilsen, O., Blystad, H., & Aavitsland, P. (2013). Trends in HIV infection surveillance data among men who have sex with men in Norway, 1995-2011. BMC public health, 13, 144.

Jenssen, G. R., Hovland, E., Bjerre, A., Bangstad, H. J., Nygard, K., & Vold, L. (2014). Incidence and etiology of hemolytic-uremic syndrome in children in Norway, 1999-2008-a retrospective study of hospital records to assess the sensitivity of surveillance. BMC Infectious Diseases, 14, 9.

Larssen, K. W., Bergh, K., Heier, B. T., Vold, L., & Afset, J. E. (2014). All-time high tularaemia incidence in Norway in 2011: report from the national surveillance. European Journal of Clinical Microbiology & Infectious Diseases, 33(11), 1919-1926.

Riviere, J., Carabin, K., Le Strat, Y., Hendrikx, P., & Dufour, B. (2014). Bovine tuberculosis surveillance in cattle and free-ranging wildlife in EU Member States in 2013: A survey-based review. Veterinary Microbiology, 173(3-4), 323-331.

Riviere, J., Strat, Y. l., Hendrikx, P., & Dufour, B. (2014). Bovine tuberculosis surveillance in cattle and free-ranging wildlife in European Union Member States in 2013: a survey-based review. Epidemiologie et Sante Animale, 66, 117-132.

2013

Sagbakken, M., Frich, J. C., Bjune, G. A., & Porter, J. D. (2013). Ethical aspects of directly observed treatment for tuberculosis: A cross-cultural comparison. BMC Medical Ethics, 14, 25.

Status of infectious diseases in Europe. Report of the European centre for disease prevention and control (ECDC). (2013). Boletin Epidemiologico Semanal, 21(2), 14-15.

2012

Surveillance of travel-associated gastrointestinal infections in Norway, 2009-2010: Are they all actually imported? Guzman-Herrador B., Vold L., Nygard K. Embase Eurosurveillance. 17 (41) , 2012. Date of Publication: 11 Oct 2012.

Phenotypic and genotypic properties of Neisseria gonorrhoeae isolates in Norway in 2009: Antimicrobial resistance warrants an immediate change in national management guidelines.

Hjelmevoll S.O., Golparian D., Dedi L., Skutlaberg D.H., Haarr E., Christensen A., Jorgensen S., Nilsen O.J., Unemo M., Skogen V. Embase European Journal of Clinical Microbiology and Infectious Diseases. 31 (6) (pp 1181-1186), 2012. Date of Publication: June 2012.

Usefulness of health registries when estimating vaccine effectiveness during the influenza A(H1N1)pdm09 pandemic in Norway. Guzman Herrador B.R., Aavitsland P., Feiring B., Riise Bergsaker M.A., Borgen K. Embase BMC infectious diseases. 12 (pp 63), 2012. Date of Publication: 2012.

2011

Meticillin-resistant Staphylococcus aureus in Norway, a low-incidence country, 2006-2010. Elstrøm P, Kacelnik O, Bruun T, Iversen B, Hauge SH, Aavitsland P. Department of Infectious Disease Epidemiology, Norwegian Institute of Public Health, Oslo, Norway. J Hosp Infect. 2012 Jan;80(1):36-40. doi: 10.1016/j.jhin.2011.10.004. Epub 2011 Nov 25.

Epidemiology of acute and chronic hepatitis B virus infection in Norway, 1992-2009. BMC Infect Dis. 2011; 11: 153. Published online 2011 May 26. doi: 10.1186/1471-2334-11-153. Gražina Rimšelienė, Øivind Nilsen, Hilde Kløvstad,Hans Blystad, and Preben Aavitsland

Gonoré – på tide med nye retningslinjer Tidsskr Nor Laegeforen. 2011 Apr 8;131(7):671-2. doi: 10.4045/tidsskr.10.1380. Hartgill U, Jakopanec I, Vestrheim DF.

Childhood tuberculosis in the European Union/European Economic Area, 2000 to 2009. Sandgren A. Hollo V. Quinten C. Manissero D. Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations, Ovid MEDLINE(R) Daily and Ovid MEDLINE(R) Euro Surveillance: Bulletin Europeen sur les Maladies Transmissibles = European Communicable Disease Bulletin. 16(12), 2011. UI: 21457686

2010

Syphilis epidemiology in Norway, 1992-2008: Resurgence among men who have sex with men. Jakopanec I., Grjibovski A.M., Nilsen O., Aavitsland P. Embase BMC Infectious Diseases. 10 , 2009. Article Number: 105. Date of Publication: 29 Apr 2010.

Evidence for waning of latency in a cohort study of tuberculosis. Wiker H.G., Mustafa T., Bjune G.A., Harboe M. Embase BMC infectious diseases. 10 (pp 37), 2010. Date of Publication: 2010.

Screening and treatment of latent tuberculosis in a cohort of asylum seekers in Norway. Harstad I., Heldal E., Steinshamn S.L., Garasen H., Winje B.A., Jacobsen G.W. Embase Scandinavian journal of public health. 38 (3) (pp 275-282), 2010. Date of Publication: May 2010.

Evidence for waning of latency in a cohort study of tuberculosis. Wiker H.G., Mustafa T., Bjune G.A., Harboe M. Embase BMC Infectious Diseases. 10 , 2010. Article Number: 37. Date of Publication: 23 Feb 2010.

The role of entry screening in case finding of tuberculosis among asylum seekers in Norway. Harstad I., Jacobsen G.W., Heldal E., Winje B.A., Vahedi S., Helvik A.S., Steinshamn S.L., Garasen H. Embase BMC public health. 10 (pp 670), 2010. Date of Publication: 2010.

2009

The epidemiology of gonorrhoea in Norway, 1993-2007: past victories, future challenges. Jakopanec I., Borgen K., Aavitsland P. Embase BMC infectious diseases. 9 (pp 33), 2009. Date of Publication: 2009.

Surveillance and prevalence of antimicrobial resistance in Norway. <Overvaking og forekomst av antibiotikaresistens i Norge.> Simonsen G.S. Embase Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke. 129 (7) (pp 623-627), 2009. Date of Publication: 26 Mar 2009.

Tuberculosis screening and follow-up of asylum seekers in Norway: a cohort study. Harstad I., Heldal E., Steinshamn S.L., Garasen H., Jacobsen G.W. Embase BMC public health. 9 (pp 141), 2009. Date of Publication: 2009.

Tuberculosis in the EU and EEA/EFTA countries: what is the latest data telling us? Hollo V., Amato-Gauci A., Kodmon C., Manissero D.

Embase Euro surveillance : bulletin europeen sur les maladies transmissibles = European communicable disease bulletin. 14 (11) , 2009. Date of Publication: 2009.

2008

An exploratory study of disease surveillance systems in Norway. Johansen M.A., Scholl J., Aronsen G., Hartvigsen G., Bellika J.G. Embase Journal of telemedicine and telecare. 14 (7) (pp 368-371), 2008. Date of publication: 2008.

AIDS-related primary central nervous system lymphoma: a Norwegian national survey 1989-2003. Haldorsen I.S., Krakenes J., Goplen A.K., Dunlop O., Mella O., Espeland A. Embase BMC cancer. 8 (pp 225), 2008. Date of Publication: 2008.

Should children adopted from abroad be screened for methicillin-resistant Staphylococcus aureus? <Bor barn adoptert fra utlandet undersøkes for meticillinresistente stafylokokker?.> Elstrom P., Iversen B., Aavitsland P. Embase Tidsskrift for den Norske laegeforening. 128 (3) (pp 291-293), 2008. Date of Publication: 31 Jan 2008.

Meticillinresistente gule stafylokokker i Norge Petter Elstrøm, Preben Aavitsland Tidsskr Nor Legeforen nr. 23, 2008; 128: 2730–3

Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway. Vestrheim D.F., Lovoll O., Aaberge I.S., Caugant D.A., Hoiby E.A., Bakke H., Bergsaker M.R. Embase Vaccine. 26 (26) (pp 3277-3281), 2008. Date of Publication: 19 Jun 2008.

International Circumpolar Surveillance System for invasive pneumococcal disease, 1999-2005. Bruce MG. Deeks SL. Zulz T. Bruden D. Navarro C. Lovgren M. Jette L. Kristinsson K. Sigmundsdottir G. Jensen KB. Lovoll O. Nuorti JP. Herva E. Nystedt A. Sjostedt A. Koch A. Hennessy TW. Parkinson AJ. Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations, Ovid MEDLINE(R) Daily and Ovid MEDLINE(R). Emerging Infectious Diseases. 14(1):25-33, 2008 Jan. [Journal Article. Research Support, Non-U.S. Gov't. Research Support, U.S. Gov't, P.H.S.] UI: 18258073

Drug resistance in tuberculosis. <Medikamentresistens ved tuberkulose.> Winje B.A., Mannsaker T., Langeland N., Heldal E. Embase Tidsskrift for den Norske Laegeforening. 128 (22) (pp 2588-2592), 2008. Date of Publication: 20 Nov 2008.

2007

Ingen publikasjoner

2006

Incidence trend and risk factors for campylobacter infections in humans in Norway. Marianne Sandberg, Karin Nygård, Hege Meldal, Paul Steinar Valle, Hilde Kruse and Eystein Skjerve BMC Public Health 2006, 6:179

A large community outbreak of waterborne giardiasis-delayed detection in a non-endemic urban area. Karin Nygård, Barbara Schimmer, Øystein Søbstad, Anna Walde, Ingvar Tveit, Nina Langeland, Trygve Hausken and Preben Aavitsland BMC Public Health 2006, 6:141